Ozempic, Wegovy and other drugs are among 15 selected for Medicare's price negotiations
Medicare adds 15 drugs, including Ozempic and Wegovy, to its price negotiation list, aiming to save billions. Incoming Trump administration will finalize details, but obesity treatment remains uncovered under Medicare rules.
